Recent achievements and future developments in neonatal cardiopulmonary bypass

被引:10
|
作者
Bojan, Mirela [1 ]
机构
[1] Marie Lannelongue Hosp, Dept Anesthesiol, Congenital Cardiac Unit, 133 Ave Resistance, F-92350 Le Plessis Robinson, France
关键词
anticoagulation; blood products; cardiopulmonary bypass; congenital heart disease; hypothermia; monitoring devices; neonate; HYPOTHERMIC CIRCULATORY ARREST; NEAR-INFRARED SPECTROSCOPY; PEDIATRIC CARDIAC-SURGERY; BLOOD-CELL TRANSFUSION; PH-STAT STRATEGIES; AORTIC-ARCH REPAIR; CEREBRAL PERFUSION; NITRIC-OXIDE; POSTOPERATIVE MORBIDITY; CONTROLLED-TRIAL;
D O I
10.1111/pan.13597
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
A primary goal of improving neonatal cardiopulmonary bypass has been making the circuit smaller and reduce the blood contacting surfaces. As bypass circuit size has decreased, bloodless surgery has become possible even in neonates. Since transfusion guidelines are difficult to construct based on existing literature, these technical advances should be taken advantage of in conjunction with an individualized transfusion scheme, based on monitoring of oxygen availability to the tissues. For the majority of neonatal heart operations, several centers have shifted toward normothermic bypass even for complex neonatal surgeries, in order to avoid the adverse effects of hypothermia. Deep hypothermic circulatory arrest is no longer a necessity but an option, and selective antegrade cerebral perfusion has become common practice; however, technical uncertainties with regard to this technique have to be addressed, based on reliable neurologic monitoring. Maintenance of patient-specific heparin concentrations during bypass is another key goal, since neonates have lower baseline antithrombin concentrations and, therefore, a higher risk for inadequate thrombin inhibition and postoperative bleeding. Due to the immaturity of their hemostatic system, the standard coagulation tests alone are inappropriate to guide hemostatic therapy in neonates. The use of indirect heparin concentration assays and global viscoelastic assays in the operating room is likely to represent the optimal strategy, and requires validation in neonates. Monitoring of global and regional indexes of oxygen availability and consumption on bypass have become possible; however, their use in neonates still has outstanding technical issues which should be addressed and hence needs further validation. Due to the immaturity of the neonatal myocardium, single-shot cold cardioplegia solutions are thought to confer the best myocardial protection; their superiority when compared to more conventional modalities, however, remains to be demonstrated.
引用
收藏
页码:414 / 425
页数:12
相关论文
共 50 条
  • [41] USE OF FRESH WHOLE BLOOD FOR NEONATAL CARDIOPULMONARY BYPASS
    Herstine, Erin
    Gehrie, Eric
    Marshall, Christi
    Blakemore, Karin
    Hibino, Narutoshi
    Vricella, Luca
    McMillan, Kristen Nelson
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [42] PLANT BREEDING - RECENT ACHIEVEMENTS AND FUTURE PROSPECTS
    ROGERS, HH
    [J]. SPAN, 1978, 21 (02): : 51 - 53
  • [43] Recent Achievements and Future Challenges in Nanoscience and Nanotechnology
    Mansurov, Z. A.
    [J]. EURASIAN CHEMICO-TECHNOLOGICAL JOURNAL, 2020, 22 (04) : 241 - 253
  • [44] Recent topics in photoelectrochemistry: achievements and future prospects
    Tryk, DA
    Fujishima, A
    Honda, K
    [J]. ELECTROCHIMICA ACTA, 2000, 45 (15-16) : 2363 - 2376
  • [45] Recent Ecomaterial Developments and Environmental Achievements of Major Industries in Japan
    Yamada, Katsutoshi
    Ijima, Kiyoshi
    Shinohara, Yoshikazu
    Halada, Kohmei
    [J]. JOURNAL OF THE JAPAN INSTITUTE OF METALS, 2008, 72 (09) : 751 - 757
  • [46] Recent ecomaterial developments and environmental achievements of major industries in Japan
    Yamada, Katsutoshi
    Ijima, Kiyoshi
    Shmohara, Yoshikazu
    Halada, Kohmei
    [J]. MATERIALS TRANSACTIONS, 2007, 48 (12) : 3036 - 3042
  • [47] Drug treatment of tropical parasitic infections - Recent achievements and developments
    Stephenson, I
    Wiselka, M
    [J]. DRUGS, 2000, 60 (05) : 985 - 995
  • [48] Alternatives to animal testing: Achievements and recent developments in the European pharmacopoeia
    Castle, P
    [J]. REPLACEMENT, REDUCTION AND REFINEMENT OF ANIMAL EXPERIMENTS IN THE DEVELOPMENT AND CONTROL OF BIOLOGICAL PRODUCTS, 1996, 86 : 21 - 29
  • [49] Recent developments in diagnostics and treatment of neonatal cholestasis
    Feldman, Amy G.
    Sokol, Ronald J.
    [J]. SEMINARS IN PEDIATRIC SURGERY, 2020, 29 (04)
  • [50] Living Labs Past Achievements, Current Developments, and Future Trajectories
    Schuurman, Dimitri
    Leminen, Seppo
    [J]. SUSTAINABILITY, 2021, 13 (19)